Pharma
Zepbound weight loss results better than Wegovy’s, Lilly study finds
While both drugs are GLP-1s, they have different active ingredients.
Weight Loss
Payers
Biden’s proposal for government GLP-1 coverage could raise federal spending by billions
The administration proposed allowing Medicare and Medicaid to cover the drugs for weight loss, not just diabetes and cardiovascular disease.
Pharma
Pharma execs share their projections for the industry in 2025
From GLP-1s to AI, leaders share their thoughts.
Pharma
Pharma leaders talk the biggest trends of 2024
From GLP-1s to PBMs, these execs give their thoughts.
Payers
Medicaid spending on GLP-1s has skyrocketed since 2019, study finds
Spending rose more than 500% in the last five years, KFF researchers found.
Pharma
Study: 16 new obesity drugs could come to market in the next 5 years
The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
